Gauri Kaul Foundation

02/12/2025

02/12/2025

Our program at Gauri Heart Centre is very aggressive for obesity . We use counselling of life style management and wherever needed the most modern scientific pharmacotherapy using GLP1 analogues judicially . Here is an example where the wonder drug Tirzepatide ( Mounjaro ) was used resulting in weight loss of 13 kgs in 6 months . We hv examples with Semaglutide too .

Please listen .

02/12/2025

𝐍𝐞𝐰 𝐃𝐚𝐰𝐧 𝐟𝐨𝐫 𝐀𝐜𝐡𝐢𝐧𝐠 𝐇𝐞𝐚𝐫𝐭𝐬

Hypertrophic Obstructive Cardiomyopathy (HOCM) is a silent storm in the heart, a common yet often-missed genetic condition that can cast a heavy shadow over a patient’s life. Mavacamten is poised to become the cornerstone of medical therapy for symptomatic obstructive HOCM. It is a testament to translational science—moving from a molecular understanding of disease to a drug that offers genuine, life-altering benefits.

click here: https://www.greaterkashmir.com/opinion/new-dawn-for-aching-hearts/

01/12/2025

We have taken on board Ms Shereen Naman as our official spokesperson . She is an expert in journalism, mass communication a passionate advocate of kashmiri heritage , art and culture.

A founder of my story episodes an author of “ Reminiscence of the past : Antiques and souvenirs from the valley .

We wish her a very successful tenure and want her to take the GKF to further in its journey esp in our social commitnents .

01/12/2025

Our academic and collaborative programs are receiving a great attention by our Director Dr Priyadarshini Arambam . She along with Dr Abid Hussain is extending our activities in outreach areas of Shopian and kulgam districts very soon after official permissions .

17/11/2025

In this episode, we feature Dr. Upendra Kaul, Chairman & Dean – Academics & Research at Batra Hospital and Medical Research Centre, New Delhi, and a Padma Shri awardee, whose remarkable journey continues to inspire generations in the field of cardiology.

Dr. Kaul shares his powerful perspectives on India’s cardiovascular health priorities, the importance of regular check-ups, and how innovation, awareness, and early intervention can save countless lives. He also offers his take on the evolving role of AI in cardiology and the future of research in hypertrophic cardiomyopathy (HCM).

Tune in to this insightful episode as Dr. Kaul blends wisdom, science, and compassion — reminding us that the heart of healthcare lies in prevention, research, and human connection.

In this episode, we feature Dr. Upendra Kaul, Chairman & Dean – Academics & Research at Batra Hospital and Medical Research Centre, New Delhi, and a Padma Sh...

05/11/2025

On this sacred Gurpurab, remember Guru Nanak Dev Ji’s divine wisdom that peace begins within. May his light guide you through life’s journey and bless your soul with everlasting serenity. Wishing you a peaceful and joyous Guru Nanak Jayanti!

🙏 ❤️

01/11/2025

A new multicenter study presented at TCT 2025, the world’s leading scientific symposium on interventional cardiology, has found that next-generation ultrathin drug-eluting stents are both safe and effective in diabetic patients with multivessel coronary artery disease (MVD) — a group often considered for bypass surgery.

Dr Kaul emphasized that the findings challenge long-held assumptions that diabetic patients with multivessel disease are better served by bypass surgery rather than PCI. “With advances in stent design — including thinner struts, improved polymers, and refined drug delivery systems — we’re seeing excellent results even in complex diabetic cases,

click here to read: https://www.greaterkashmir.com/health/next-generation-ultrathin-stents-found-safe-effective-in-diabetic-patients-with-multivessel-coronary-artery-disease-study/

Priyadarshini Arambam Upendra Kaul Gauri Kaul Foundation

Researchers said the low rates of restenosis, stent thrombosis, and myocardial infarction demonstrate the significant impact of design evolution in drug-eluting stent technology.

31/10/2025

The session titled “India’s Undiagnosed Heart: Hypertrophic Cardiomyopathy Is More Common Than We Think” brought together leading clinicians, researchers, policymakers, and patient advocates to address the urgent need for awareness, early detection, and structured management of this complex cardiac condition.

The session titled “India’s Undiagnosed Heart: Hypertrophic Cardiomyopathy Is More Common Than We Think” brought together leading clinicians, researchers, po...